ROSAI-DORFMAN DISEASE (RDD)

Clinical trials for ROSAI-DORFMAN DISEASE (RDD) explained in plain language.

Never miss a new study

Get alerted when new ROSAI-DORFMAN DISEASE (RDD) trials appear

Sign up with your email to follow new studies for ROSAI-DORFMAN DISEASE (RDD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for kids with rare, dangerous blood disease

Disease control Recruiting now

This study is testing an oral drug called mirdametinib for people with rare histiocytic disorders like Langerhans Cell Histiocytosis (LCH). It aims to see if this targeted treatment works better and has fewer side effects than current chemotherapy, especially for patients whose d…

Matched conditions: ROSAI-DORFMAN DISEASE (RDD)

Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

ROSAI-DORFMAN DISEASE (RDD)

Get alerted when new ROSAI-DORFMAN DISEASE (RDD) trials appear

New drug trial offers hope for kids with rare, dangerous blood disease